• AFF2 (AF4/FMR2 family, member 2) Gene Mutation Analysis
  • Paroxysmal Nocturnal Hemoglobinuria (PNH) (CD55, CD59), Flow, Blood
  • Hereditary Hemolytic Anemia Gene Mutation Panel, NGS
  • Cancer Antigen (CA) 19-9, Peritoneal Fluid
  • Rickettsia Antibody Panel, IgG and IgM
  • MDMA, Urine
  • Antithrombin Activity
  • Hemoglobin A1c
  • Electrophoresis, Protein, CSF
  • HLA Class II DR, DQ and DP Genotyping (HLA-DRB1, -DRB3/4/5, -DQB1, -DQA1, -DPB1, or -DPA1)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /DetermaRx for Lung Cancer Disease Management
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

DetermaRx for Lung Cancer Disease Management
Medical Test

Diseases (2)
Access to DetermaRx for Lung Cancer Disease Management is restricted.